debrisoquin has been researched along with Anoxemia in 1 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bialkowska, M | 1 |
| Zajac, D | 1 |
| Mazzatenta, A | 1 |
| Di Giulio, C | 1 |
| Pokorski, M | 1 |
1 review available for debrisoquin and Anoxemia
| Article | Year |
|---|---|
Inhibition of peripheral dopamine metabolism and the ventilatory response to hypoxia in the rat.
Topics: Adaptation, Physiological; Animals; Blood Pressure; Carotid Body; Catechol O-Methyltransferase; Cate | 2015 |